FY 2026 marked a significant inflection point for Aspen as the Group delivered strong normalised earnings growth, improved profitability across both Commercial Pharmaceuticals and Manufacturing, and successfully completed the APAC divestment.
FY 2026 marked a significant inflection point for Aspen as the Group delivered strong normalised earnings growth, improved profitability across both Commercial Pharmaceuticals and Manufacturing, and successfully completed the APAC divestment.
Aspen has concluded a voluntary licensing agreement with MSD to develop, manufacture and commercialise alimatravir, a monthly oral dose of medicine used for the prevention of HIV-1.
Aspen is marking the 16th consecutive year of its Mandela Day campaign which has reached more than 920 000 beneficiaries over this period.
Aspen is proud to celebrate Stavros Nicolaou, Group Senior Executive at Aspen Pharma Group, on receiving the prestigious Lifetime Leadership Award at the 2026 Future of Leadership Awards.
Aspen Pharmacare Holdings Limited (âAspenâ) today announced the successful completion of the divestment of its Asia Pacific (âAPACâ) business comprising Australia, New Zealand and other Asia Pacific regions (excluding China)
Aspen Pharmacare (âAspenâ) and Africa Centres for Disease Control and Prevention (âAfrica CDCâ) are in advanced discussions on a long-term demand and supply alignment framework aimed at strengthening sustainable vaccine manufacturing in Africa.
Stephen Saad joined Bronwyn Nielsen on Moneyweb TVâs flagship interview series, The Executive Exchange, to unpack his insightful and passionate leadership thinking, strategic decisionâmaking, and the forces influencing sustainable business growth in the challenging pharmaceutical sector in South Africa and internationally.
Aspen Pharmacare Holdings has reported unaudited Group interim financial results for the six months ended 31 December 2025.
Our career opportunities are across the corporate spectrum, including Human Capital, Digital Technology, Legal, and Risk & Sustainability. Our employees are given the opportunity to hone their skills and develop the experience of excellence in their chosen field in the pharmaceutical industry.
